Biodesix (BDSX) vs Fulgent Genetics (FLGT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biodesix (BDSX) has outperformed Fulgent Genetics (FLGT) over the past year, gaining 261.9% versus a loss of 9.1%. Over five years, FLGT leads with a -73.6% price change compared with -82.4% for BDSX. Fulgent Genetics is the larger company by market cap ($572.9 million vs $270.4 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDSX | FLGT |
|---|---|---|
| Share price | $25.63 | $20.82 |
| Market cap | $270.43M | $572.87M |
| 1-day change | -2.99% | +1.22% |
| YTD return | +288.53% | -21.70% |
| 1-year return | +261.92% | -9.10% |
| 5-year return | -82.39% | -73.63% |
| EPS (TTM) | $-3.10 | $-2.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.97 | $31.04 |
| 52-week low | $5.26 | $13.46 |
| Distance from 52-week high | -19.83% | -32.93% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +45.65% | -8.74% |
| Average volume | 100.74K | 298.26K |
| Shares outstanding | 10.55M | 27.52M |
| Employees | 334 | 1,315 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fulgent Genetics is about 2.1 times larger than Biodesix by market value ($572.87M vs $270.43M).
- BDSX has outperformed FLGT by 271.0 percentage points over the past year.
About Biodesix
BDSX stock →Biodesix, Inc. operates as a diagnostic solutions company.
Health Care · Medical Specialities · 334 employees
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Health Care · Medical Specialities · 1,315 employees
BDSX vs FLGT FAQ
Which is bigger, Biodesix or Fulgent Genetics?
Fulgent Genetics (FLGT) is larger, with a market capitalization of $572.87M compared with $270.43M for Biodesix (BDSX).
Which stock has performed better over the past year, BDSX or FLGT?
BDSX returned +261.92% over the past 12 months, compared with -9.10% for FLGT (price return, excluding dividends). Past performance does not predict future results.
Are Biodesix and Fulgent Genetics in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.